Recall report: Another month, another issue with NDMA
It’s been six months since the last incident, but 2021 ended with the tally resetting back to “zero days.”
Viona Pharmaceuticals is recalling 33 lots of metformin hydrochloride after finding traces of NDMA, a known probable human carcinogen with cancer-causing potential. It’s a much larger recall than the two lots of 750 mg extended-release tablets it recalled in June.
Metformin is used to help improve glucose control in adults with type 2 diabetes, and is packaged in bottles of 100 tablets. The drug can be identified by its capsule-shaped, uncoated off-white color tablets that feature a “Z” and a “C” on one side and “20” on the other.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
